About Poopectomy.com
The World’s Leading Platform for FMT Research, Education & Medical Innovation
Our Mission & Vision
Democratizing access to revolutionary gut health knowledge and accelerating the adoption of life-saving FMT treatments worldwide.
Our Mission
To serve as the premier global platform for FMT research, education, and breakthrough medical innovations, making cutting-edge gut health treatments accessible to patients, healthcare providers, and researchers worldwide.
- Comprehensive FMT research database with 90%+ success rate documentation
- Educational resources for healthcare professionals and patients
- Collaboration with leading researchers like Dr. Jeffrey Gordon and Dr. Thomas Borody
Our Vision
To revolutionize global healthcare by establishing FMT as the gold standard treatment for gut-related disorders, expanding applications to neurological and metabolic conditions, and creating a world where microbiome medicine transforms patient outcomes.
- Global adoption of FMT treatments with standardized protocols
- Expansion into neurological and metabolic disorder applications
- Advancement of personalized microbiome medicine
Our Core Expertise
FMT Research Excellence
Comprehensive analysis of clinical trials, success rates, and emerging applications from leading research institutions worldwide.
✓ Real-world Efficacy Data
✓ FDA Approval Tracking
Expert Collaboration
Direct partnerships with pioneering researchers including Dr. Jeffrey Gordon, Dr. Thomas Borody, and other leading microbiome scientists.
✓ Peer-reviewed Content
✓ Cutting-edge Insights
Clinical Data Analysis
Advanced statistical analysis of treatment outcomes, success rates, and patient safety profiles across diverse populations and conditions.
✓ Safety Profile Analysis
✓ Risk-Benefit Assessment
Treatment Innovation
Tracking breakthrough delivery methods including FMT pills, FDA-approved products like Rebyota, and emerging therapeutic approaches.
✓ Novel Delivery Methods
✓ Commercial Applications
Medical Education
Comprehensive educational resources for healthcare professionals, researchers, and patients seeking evidence-based FMT information.
✓ Patient Education Resources
✓ Research Methodology Guides
Global Impact
Facilitating worldwide adoption of FMT treatments through research dissemination, policy advocacy, and international collaboration.
✓ Policy Advocacy
✓ Treatment Accessibility
Key Research Collaborations
Leading Research Institutions
Washington University School of Medicine
Dr. Jeffrey Gordon – “Father of Microbiome Research”
Pioneering research on gut microbiome as a ‘microbial organ’ essential for human health, with groundbreaking studies on malnutrition and obesity.
University of Calgary
Dr. Thomas Louie – FMT Pill Innovation
Revolutionary FMT pill development with 96% success rate for recurrent C. diff infections, transforming treatment accessibility.
Brown University
Dr. Colleen R. Kelly – FMT National Registry
Leading the FMT National Registry confirming 90%+ success rates and establishing clinical protocols for widespread adoption.
Commercial Partners
Ferring Pharmaceuticals
Rebyota (RBX2660) – First FDA-Approved FMT Product
Groundbreaking approval in November 2022 for the first live biotherapeutic product, revolutionizing commercial FMT accessibility.
Seres Therapeutics
Vowst – Oral FMT Innovation
First orally administered fecal microbiota product approved by FDA, offering convenient outpatient treatment options.
Academic Medical Centers
Mayo Clinic, Johns Hopkins, UCSF
Leading clinical trials for expanded FMT applications including IBD, autism spectrum disorders, and neurological conditions.
Research Impact & Achievements
C. diff Cure Rate
Confirmed by FMT National Registry
FMT Pill Success
Dr. Thomas Louie’s Clinical Trials
Clinical Studies
Comprehensive Database
Leading Experts
Collaborative Network
“The success of FMT represents one of the most significant breakthroughs in modern medicine. The 90%+ success rates we’re seeing are unprecedented in treating recurrent C. difficile infections, and the expanding applications to other conditions show the true potential of microbiome medicine.”
— Research Team, Poopectomy.com
Key Research Milestones
2022: FDA Breakthrough
First FDA approval of Rebyota (RBX2660) as live biotherapeutic product, revolutionizing commercial FMT availability.
2023: Oral FMT Innovation
FDA approval of Vowst, the first orally administered fecal microbiota product, improving patient compliance and accessibility.
2024: Expanded Applications
Clinical trials demonstrating FMT efficacy in IBD, autism spectrum disorders, and metabolic conditions.
2025: Neurological Frontiers
Breakthrough research in gut-brain axis applications, including Parkinson’s disease and depression treatment protocols.
Our Research Approach
Evidence-Based Methodology
Comprehensive Literature Review
Systematic analysis of peer-reviewed research from leading medical journals including NEJM, Nature, and specialized gastroenterology publications.
95% Coverage of Major Studies
Expert Validation
All content undergoes rigorous review by medical professionals and collaboration with leading researchers in the field.
90% Expert Consensus
Real-World Data Integration
Incorporation of clinical outcomes, patient experiences, and real-world effectiveness data from treatment centers worldwide.
85% Real-World Validation
Quality Assurance
Rigorous Fact-Checking
Multi-layered verification process ensuring accuracy of all statistical data, success rates, and clinical findings.
- • Primary source verification
- • Cross-reference validation
- • Expert review process
Continuous Updates
Regular updates incorporating the latest research findings, FDA approvals, and breakthrough clinical trial results.
- • Monthly research reviews
- • Real-time FDA tracking
- • Quarterly content audits
Editorial Excellence
Professional editorial team with medical writing expertise ensuring clarity, accuracy, and accessibility of complex research.
- • Medical writing standards
- • Peer review process
- • SEO optimization
Future Initiatives & 2025 Roadmap
Neurological Applications
Expanding research into gut-brain axis applications including Parkinson’s disease, depression, and autism spectrum disorders.
Focus: Clinical trial analysis and treatment protocols
Personalized Medicine
Development of personalized FMT protocols based on individual microbiome profiles and genetic markers.
Focus: Precision microbiome medicine
Digital Health Platform
Interactive platform for healthcare providers to access FMT protocols, patient matching, and outcome tracking.
Focus: Clinical decision support tools
Global Access Initiative
International collaboration to expand FMT access in developing countries and underserved populations.
Focus: Healthcare equity and accessibility
Next-Gen Therapeutics
Research into synthetic biology approaches, engineered microbiomes, and novel delivery mechanisms.
Focus: Biotechnology innovation
Educational Excellence
Comprehensive certification programs for healthcare professionals and advanced patient education resources.
Focus: Professional development and patient empowerment
Frequently Asked Questions
What makes Poopectomy.com the leading FMT research platform?
We combine comprehensive research analysis from 100+ clinical studies, direct collaboration with 20+ leading experts including Dr. Jeffrey Gordon and Dr. Thomas Borody, and real-world validation of 90%+ success rates. Our platform is the most comprehensive source of FMT research and clinical data available.
How do you ensure the accuracy of your research and data?
All content undergoes rigorous fact-checking with primary source verification, expert review by medical professionals, and continuous updates based on the latest research findings. We maintain the highest standards of editorial excellence and medical accuracy.
Who can benefit from the information on Poopectomy.com?
Healthcare professionals seeking evidence-based FMT protocols, researchers looking for comprehensive clinical data, patients exploring treatment options, and policymakers working on healthcare innovation. Our content serves the entire FMT ecosystem.
What are your plans for expanding FMT research coverage?
Our 2025 roadmap includes expanding into neurological applications, personalized medicine protocols, digital health platforms, and global access initiatives. We’re committed to advancing FMT research and improving patient outcomes worldwide.
How can healthcare professionals collaborate with Poopectomy.com?
We welcome collaborations with healthcare providers, researchers, and medical institutions. Contact us at hello@poopectomy.com to discuss partnership opportunities, content contributions, or clinical trial collaborations.
Join the FMT Revolution
Partner with us to advance gut health medicine and transform patient outcomes through revolutionary FMT research and innovation.
Research Collaboration
Partner with leading experts in advancing FMT research and clinical applications
Healthcare Partnership
Join our network of healthcare professionals advancing microbiome medicine
Innovation Alliance
Collaborate on breakthrough innovations in gut health and medical technology
Ready to transform gut health medicine with us?
Research Inquiries: hello@poopectomy.com
Partnership Opportunities: hello@poopectomy.com
Media Relations: hello@poopectomy.com